Skin Changes in Head and Neck Cancer During Immuno-(Chemo-) And Radiotherapy With Erbitux® (HICARE)
Status:
Unknown status
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
This is a national multicenter phase IV study to assess acute radiation dermatitis of
combined radioimmuno(chemo)therapy with Cetuximab in patients with locally advanced,
non-metastatic squamous cell carcinoma of the head and neck (LASCCHN).